These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1719036)

  • 1. Recurrent hepatocellular carcinoma: usefulness of ultrasonography compared with computed tomography and AFP assay.
    Shibata T; Kubo S; Itoh K; Sagoh T; Nishimura K; Nakano Y; Yamaoka Y; Ozawa K; Konishi J
    J Clin Ultrasound; 1991 Oct; 19(8):463-9. PubMed ID: 1719036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Takada A; Fukumori K; Yano Y; Sumie S; Okuda K; Kumashiro R; Sata M
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):641-8. PubMed ID: 12840676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of recurrent hepatocellular carcinoma.
    Nishizaki T; Takenaka K; Yanaga K; Soejima Y; Uchiyama H; Kishikawa K; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):508-13. PubMed ID: 9164527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom.
    Han AR; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2009; 56(93):1111-6. PubMed ID: 19760952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-guided fine needle biopsy of intrahepatic nodules and low elevation of AFP in early diagnosis of hepatocellular carcinoma.
    He YM; Wang XY; Gao SD; Yu LY; Lin XD; Lin LW
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):50-4. PubMed ID: 15730919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probability of hepatocellular carcinoma of small hepatocellular nodules undetectable by computed tomography during arterial portography.
    Tanaka Y; Sasaki Y; Katayama K; Hiramatsu N; Ito A; Murata H; Enomoto N; Oshita M; Mochizuki K; Tsujii M; Tsuji S; Kasahara A; Tomoda K; Nakamura H; Hayashi N; Hori M
    Hepatology; 2000 Apr; 31(4):890-8. PubMed ID: 10733545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
    J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America.
    Tong MJ; Blatt LM; Kao VW
    J Gastroenterol Hepatol; 2001 May; 16(5):553-9. PubMed ID: 11350553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin affinity electrophoresis of alpha-fetoprotein. Increased specificity and sensitivity as a marker of hepatocellular carcinoma.
    Hirai H; Taketa K
    J Chromatogr; 1992 Jun; 604(1):91-4. PubMed ID: 1379253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Did AFP-L3 save ultrasonography in community screening?
    Yen CW; Kuo YH; Wang JH; Chang KC; Kee KM; Hung SF; Chen Y; Tsai LS; Chen SC; Hung CH; Lu SN
    Kaohsiung J Med Sci; 2018 Oct; 34(10):583-587. PubMed ID: 30309487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis.
    Okano H; Shiraki K; Inoue H; Ito T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Nakano T
    Anticancer Res; 2001; 21(4B):2979-82. PubMed ID: 11712797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
    Chen Z; Liang H; Zhang X; Wang X; Chen W; Shi X; Yi C; Rao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1615-9. PubMed ID: 23174588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein level?].
    Shin WY; Suh KS; Kim T; Jeon YM; Yi NJ; Lee KU
    Korean J Hepatol; 2010 Jun; 16(2):168-75. PubMed ID: 20606501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography].
    Barletta E; Tinessa V; Daniele B
    Recenti Prog Med; 2005 Jun; 96(6):295-9; quiz 328. PubMed ID: 16078760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
    Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L
    Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.
    Siripongsakun S; Wei SH; Lin S; Chen J; Raman SS; Sayre J; Tong MJ; Lu DS
    J Gastroenterol Hepatol; 2014 Jan; 29(1):157-64. PubMed ID: 24354994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns.
    Ferris JV; Baron RL; Marsh JW; Oliver JH; Carr BI; Dodd GD
    Radiology; 1996 Jan; 198(1):233-8. PubMed ID: 8539385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early diagnosis of hepatocellular carcinoma].
    Hirooka N; Matsuura N; Ohto M
    Nihon Rinsho; 1994 Jan; 52(1):69-74. PubMed ID: 7509420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma.
    Okamura Y; Ashida R; Ito T; Sugiura T; Mori K; Uesaka K
    Surg Today; 2015 Dec; 45(12):1513-20. PubMed ID: 25527455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.